CSPC Pharmaceutical Group Limited (02509.HK) repurchased 156,400 shares for 2.983 million Hong Kong dollars on November 10th.

The latest news from DZH Financial APP: Quanxin Biotech-B (02509.HK) announced that the company repurchased 156,400 shares at a total cost of HK$2,998,300 on November 10, 2025, with a repurchase price of HK$18.42-19.84 per share.